Free Trial

LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$6.60 -0.17 (-2.51%)
Closing price 03/26/2025 04:00 PM Eastern
Extended Trading
$6.72 +0.12 (+1.74%)
As of 03/26/2025 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LFST vs. HIMS, OPCH, GH, RDNT, SHC, SGRY, BTSG, PRVA, CON, and WGS

Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry.

LifeStance Health Group vs.

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, community ranking, dividends, valuation, institutional ownership and earnings.

In the previous week, Hims & Hers Health had 24 more articles in the media than LifeStance Health Group. MarketBeat recorded 26 mentions for Hims & Hers Health and 2 mentions for LifeStance Health Group. Hims & Hers Health's average media sentiment score of 1.08 beat LifeStance Health Group's score of 0.82 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
18 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

LifeStance Health Group presently has a consensus target price of $8.63, indicating a potential upside of 30.68%. Hims & Hers Health has a consensus target price of $37.31, indicating a potential upside of 11.72%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, equities analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Hims & Hers Health
2 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.27

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.25B2.03-$186.26M-$0.16-41.25
Hims & Hers Health$1.48B5.02-$23.55M$0.5461.84

Hims & Hers Health received 31 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 37.07% of users gave Hims & Hers Health an outperform vote while only 27.91% of users gave LifeStance Health Group an outperform vote.

CompanyUnderperformOutperform
LifeStance Health GroupOutperform Votes
12
27.91%
Underperform Votes
31
72.09%
Hims & Hers HealthOutperform Votes
43
37.07%
Underperform Votes
73
62.93%

LifeStance Health Group has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500.

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Hims & Hers Health has a net margin of 8.19% compared to LifeStance Health Group's net margin of -7.90%. Hims & Hers Health's return on equity of 10.97% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group-7.90% -6.66% -4.51%
Hims & Hers Health 8.19%10.97%8.29%

Summary

Hims & Hers Health beats LifeStance Health Group on 15 of the 18 factors compared between the two stocks.

Remove Ads
Get LifeStance Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

MetricLifeStance Health GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.54B$877.57M$5.62B$8.13B
Dividend YieldN/A2.41%4.56%4.00%
P/E Ratio-25.3846.5524.5419.09
Price / Sales2.033.53386.7694.71
Price / CashN/A26.1438.1634.64
Price / Book1.752.746.974.36
Net Income-$186.26M-$5.50M$3.20B$247.23M
7 Day Performance-3.23%0.01%-2.19%-0.34%
1 Month Performance-14.73%-9.19%3.14%-3.60%
1 Year Performance9.63%70.68%11.39%2.01%

LifeStance Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
2.4797 of 5 stars
$6.60
-2.5%
$8.63
+30.7%
+10.9%$2.54B$1.25B-25.386,640Positive News
HIMS
Hims & Hers Health
3.2611 of 5 stars
$34.68
+4.6%
$37.23
+7.4%
+111.2%$7.70B$1.48B78.821,046Positive News
OPCH
Option Care Health
3.9556 of 5 stars
$33.89
+3.8%
$33.00
-2.6%
+6.6%$5.60B$5.00B28.485,600Positive News
GH
Guardant Health
3.7107 of 5 stars
$42.90
+0.0%
$48.40
+12.8%
+159.1%$5.29B$739.02M-12.051,790Analyst Forecast
News Coverage
RDNT
RadNet
3.8633 of 5 stars
$49.02
+5.3%
$76.75
+56.6%
+5.0%$3.63B$1.83B-700.198,970Analyst Forecast
High Trading Volume
SHC
Sotera Health
2.8528 of 5 stars
$11.93
+2.9%
$15.92
+33.4%
+1.4%$3.38B$1.10B47.723,000
SGRY
Surgery Partners
2.3252 of 5 stars
$24.40
+3.4%
$36.63
+50.1%
-17.7%$3.11B$3.11B-50.8313,500Analyst Forecast
BTSG
BrightSpring Health Services
2.5423 of 5 stars
$17.45
+0.2%
$21.67
+24.2%
+87.3%$3.05B$11.27B-67.1235,000Gap Up
PRVA
Privia Health Group
3.6412 of 5 stars
$23.24
-2.1%
$26.67
+14.7%
+20.6%$2.80B$1.74B232.421,102Positive News
CON
Concentra Group Holdings Parent
N/A$21.04
+1.2%
$28.38
+34.8%
N/A$2.68B$1.90B13.9411,000Positive News
WGS
GeneDx
2.3599 of 5 stars
$94.46
-4.1%
$72.33
-23.4%
+1,003.4%$2.65B$305.45M-48.191,200Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:LFST) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners